James T. Boyd
Department of Neurological Sciences
University of Vermont
United States of America
Biography
Prof James T. Boyd, his M.D., Memorial University of Newfoundland, St. John's, Newfoundland, Canada. He has successfully completed her Administrative responsibilities as Professor. His research has included Neuroprotective therapies in Parkinson's disease, Behavioral changes in movement disorders, Nicotine in Parkinson's disease.
Research Interest
Neuroprotective therapies in Parkinson's disease, Behavioral changes in movement disorders, Nicotine in Parkinson's disease.
Publications
-
Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA neurology. 2014 May 1;71(5):543-52.
-
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. JNCI: Journal of the National Cancer Institute. 1990 Jul 4;82(13):1107-12.
-
Aubert B, Boutigny D, Gaillard JM, Hicheur A, Karyotakis Y, Lees JP, Robbe P, Tisserand V, Zghiche A, Palano A, Pompili A. Measurement of the C P Asymmetry Amplitude sin 2 β with B 0 Mesons. Physical Review Letters. 2002 Oct 29;89(20):201802.
